JOHN JOHNSON

Insider Reports History

Location
Seattle, WA
Signature
/s/ Beth Hecht, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by JOHN JOHNSON:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xeris Biopharma Holdings, Inc. Director Common Stock 698K $5.04M $7.22 19 Dec 2025 Direct
Applied Therapeutics, Inc. Executive Chairman, Director Common Stock 500K $2.92M $5.83 19 Dec 2024 Direct
Verastem, Inc. Director Common Stock 16.7K $116K $6.99 22 May 2025 Direct
Axogen, Inc. Director Restricted Stock Units 14.2K $0 $7.68 19 Jun 2025 Direct
Axogen, Inc. Director Common Stock 0 $0 $29.98 09 Dec 2025 Direct
Applied Therapeutics, Inc. Executive Chairman, Director Stock Option (Right to Buy) 1M 19 Dec 2024 Direct
Verastem, Inc. Director Stock Option (right to buy) 12.5K 22 May 2025 Direct
Axogen, Inc. Director Stock Option (right to purchase) 0 09 Dec 2025 Direct
Strongbridge Biopharma plc Chief Executive Officer, Director Ordinary Shares 0 $2.06 05 Oct 2021 Direct
Strongbridge Biopharma plc Chief Executive Officer, Director Stock Option (Right to Buy) 0 05 Oct 2021 Direct

Insider Reports Filed by JOHN JOHNSON

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XERS Xeris Biopharma Holdings, Inc. 19 Dec 2025 1 -$977K 4 Director 19 Dec 2025, 17:17
AXGN Axogen, Inc. 08 Dec 2025 8 -$1.26M 4 Director 10 Dec 2025, 17:19
XERS Xeris Biopharma Holdings, Inc. 13 Aug 2025 1 -$786K 4 Director 15 Aug 2025, 16:57
AXGN Axogen, Inc. 19 Jun 2025 1 $0 4 Director 20 Jun 2025, 16:11
AXGN Axogen, Inc. 09 Jun 2025 1 -$43.2K 4 Director 11 Jun 2025, 16:23
XERS Xeris Biopharma Holdings, Inc. 04 Jun 2025 1 $0 4 Director 04 Jun 2025, 19:01
VSTM Verastem, Inc. 22 May 2025 2 $0 4 Director 27 May 2025, 17:42
APLT Applied Therapeutics, Inc. 19 Dec 2024 2 $0 4 Executive Chairman, Director 20 Dec 2024, 20:30
APLT Applied Therapeutics, Inc. 19 Dec 2024 0 $0 3 Executive Chairman, Director 20 Dec 2024, 20:30
AXGN Axogen, Inc. 01 Sep 2024 2 $0 4 Director 04 Sep 2024, 21:13
VSTM Verastem, Inc. 18 Jun 2024 2 $0 4 Director 20 Jun 2024, 20:27
AXGN Axogen, Inc. 06 Jun 2024 2 $0 4 Director 10 Jun 2024, 18:20
XERS Xeris Biopharma Holdings, Inc. 05 Jun 2024 1 $0 4 Director 05 Jun 2024, 16:18
XERS Xeris Biopharma Holdings, Inc. 18 Mar 2024 2 $429K 4 Director 18 Mar 2024, 17:32
XERS Xeris Biopharma Holdings, Inc. 15 Mar 2024 1 $0 4 Director 01 Apr 2024, 17:43
VSTM Verastem, Inc. 11 Mar 2024 5 $0 4 Director 13 Mar 2024, 18:14
AXGN Axogen, Inc. 01 Sep 2023 2 $0 4 Director 07 Sep 2023, 06:29
XERS Xeris Biopharma Holdings, Inc. 07 Jun 2023 1 $0 4 Director 07 Jun 2023, 16:59
AXGN Axogen, Inc. 01 Jun 2023 2 $0 4 Director 05 Jun 2023, 18:53
VSTM Verastem, Inc. 15 May 2023 1 $0 4 Director 16 May 2023, 16:33
VSTM Verastem, Inc. 22 Jun 2022 1 $0 4 Director 24 Jun 2022, 16:11
XERS Xeris Biopharma Holdings, Inc. 08 Jun 2022 2 $0 4 Director 09 Jun 2022, 17:13
AXGN Axogen, Inc. 01 Jun 2022 2 $0 4 Director 03 Jun 2022, 16:14
VSTM Verastem, Inc. 12 May 2022 1 $0 4/A Director 20 Dec 2022, 15:07
XERS Xeris Biopharma Holdings, Inc. 05 Oct 2021 8 $46.6K 4/A Director 08 Oct 2021, 18:29
SBBP Strongbridge Biopharma plc 05 Oct 2021 2 $0 4 Chief Executive Officer, Director 06 Oct 2021, 19:42
XERS Xeris Biopharma Holdings, Inc. 05 Oct 2021 0 $0 3 Director 05 Oct 2021, 17:22
SBBP Strongbridge Biopharma plc 01 Oct 2021 1 -$690K 4 Chief Executive Officer, Director 05 Oct 2021, 19:24
AXGN Axogen, Inc. 19 Jul 2021 1 $0 4 Director 21 Jul 2021, 16:10
AXGN Axogen, Inc. 19 Jul 2021 0 $0 3 Director 21 Jul 2021, 16:05
SBBP Strongbridge Biopharma plc 02 Jul 2021 1 -$157K 4 Chief Executive Officer, Director 07 Jul 2021, 17:01
VSTM Verastem, Inc. 28 Jun 2021 1 $0 4 Director 30 Jun 2021, 14:00